tiprankstipranks
Trending News
More News >
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Income Statement

Compare
9 Followers

Avecho Biotechnology Limited Income Statement

Last quarter (Q2 2025), Avecho Biotechnology Limited's total revenue was AU$280.04K, a decrease of -37.27% from the same quarter last year. In Q2, Avecho Biotechnology Limited's net income was AU$-1.34M. See Avecho Biotechnology Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 1.13MAU$ 473.55KAU$ 1.13MAU$ 793.60KAU$ 384.63K
Gross Profit
AU$ 671.93KAU$ -43.80KAU$ 793.12KAU$ 507.94KAU$ 240.91K
Operating Expenses
AU$ 5.63MAU$ 4.55MAU$ 3.86MAU$ 5.06MAU$ 3.65M
Depreciation and Amortization
AU$ 144.88KAU$ 178.69KAU$ 230.35KAU$ 428.59KAU$ 536.63K
EBITDA
AU$ -2.92MAU$ -3.24MAU$ -2.11MAU$ -2.98MAU$ -2.45M
Operating Income
AU$ -4.96MAU$ -4.59MAU$ -3.06MAU$ -4.55MAU$ -3.39M
Other Income/Expenses
AU$ 1.84MAU$ 77.06KAU$ 98.55KAU$ 1.13MAU$ 772.16K
Pretax Income
AU$ -3.12MAU$ -4.51MAU$ -2.96MAU$ -4.54MAU$ -3.00M
Net Income
AU$ -3.12MAU$ -3.44MAU$ -2.34MAU$ -3.42MAU$ -2.63M
Per Share Metrics
Basic EPS
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Diluted EPS
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Weighted Average Shares Outstanding
3.12B 2.27B 1.80B 1.80B 1.55B
Weighted Average Shares Outstanding (Diluted)
3.12B 2.27B 1.84B 1.80B 1.59B
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History